OVER 2.6 MILLION PATIENTS PRESCRIBED WORLDWIDE*

Gastroenterology

Moderately to severely active

Crohn's disease

Moderately to severely active

Pediatric Crohn's disease

Moderately to severely active

Ulcerative Colitis

Moderately to severely active

Pediatric Ulcerative Colitis

Rheumatology

Moderately to severely active

Rheumatoid Arthritis

Active

Psoriatic Arthritis

Active

Ankylosing Spondylitis

Dermatology

Chronic severe

Plaque Psoriasis

Janssen Immunology

*Cumulative exposure from August 1998 through August 2016. Uses include rheumatoid arthritis, Crohn's disease, psoriatic arthritis, ankylosing spondylitis, plaque psoriasis, and ulcerative colitis.